diazoxide hyperinsulinism
Selected indexed studies
- International Guidelines for the Diagnosis and Management of Hyperinsulinism. (Horm Res Paediatr, 2024) [PMID:37454648]
- Genotype and phenotype correlations in 417 children with congenital hyperinsulinism. (J Clin Endocrinol Metab, 2013) [PMID:23275527]
- Management and Appropriate Use of Diazoxide in Infants and Children with Hyperinsulinism. (J Clin Endocrinol Metab, 2020) [PMID:32810255]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- International Guidelines for the Diagnosis and Management of Hyperinsulinism. (2024) pubmed
- Genotype and phenotype correlations in 417 children with congenital hyperinsulinism. (2013) pubmed
- Management and Appropriate Use of Diazoxide in Infants and Children with Hyperinsulinism. (2020) pubmed
- Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism. (2013) pubmed
- Dasiglucagon: A New Hope for Diazoxide-unresponsive, Nonfocal Congenital Hyperinsulinism? (2024) pubmed
- Commentary on studies investigating low-dose diazoxide in hyperinsulinism. (2024) pubmed
- Diazoxide for hyperinsulinism. (1970) pubmed
- Congenital hyperinsulinism. (2010) pubmed
- Low-dose diazoxide is safe and effective in infants with transient hyperinsulinism. (2024) pubmed
- The hyperinsulinism/hyperammonemia syndrome. (2010) pubmed